Conference Correspondent

Artificial intelligence holds promise for detecting lung cancer if research presented last month at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer is any indicator. Read More ›

Data presented at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer add another piece to the puzzle of people diagnosed with lung cancer who never smoked. Read More ›

Sexual Dysfunction After Cancer: Why Aren’t We Talking About It?

According to D. Kathryn Tierney, PhD, RN, cancer survivors, patients, and their providers are not talking about the incidence of sexual dysfunction, which can have a negative impact on cancer survivors’ quality of life as well as their intimate partners.

Read More ›

The Importance of Compassion: Perspective From a Lifelong Patient

Compassion is defined as a feeling of deep sorrow for another’s pain, accompanied by an equally powerful desire to lessen or remove their suffering, be it mental, physical, or emotional. The difference between empathy and compassion is action.

Read More ›

Using a Team Approach to Tackle Opioid Abuse in Patients with Cancer
“The longer a patient is on pain medicine, the harder it is to come off of it and the more it’s going to predict issues later on, so we have to continue to be vigilant,” explained Tonya Edwards, MS, MSN, FNP-C, at the Oncology Nursing Society 2018 Congress. Read More ›

Addressing the Second Victim Phenomenon

At the Oncology Nursing Society 2018 Congress, Susan D. Scott, PhD, RN, addresses the secondary trauma endured by clinicians when a patient dies because of an unexpected medical event, and the peer-to-peer support team that she and her colleagues formed at her clinic.

Read More ›

Humanizing Cancer Care: The Patient Perspective

At the ACCC National Oncology Conference in October 2017, Brianne Joseph, LPI, brought the audience to their feet with a compelling message for those involved in cancer care.

Read More ›

Quizartinib Combinations Show High Activity in Newly Diagnosed Acute Myeloid Leukemia with FLT3 Mutation

The combination of the investigational drug quizartinib plus azacitidine (Vidaza) or low-dose cytarabine has substantial activity in patients with myeloid leukemias and FLT3 mutations.

Read More ›

Combining Immunotherapy and Radiotherapy Shows Good Synergy

As the number of patients receiving immune checkpoint blockade grows, the combination of radiation and immunotherapy has become increasingly relevant, particularly in the palliative care setting, where radiation therapy is used to treat painful lesions or brain metastases.

Read More ›

Measuring Financial Well-Being in Cancer Survivorship

To effectively address socioeconomic disparities in healthcare, it is critical that we improve our understanding of the material, psychosocial, and behavioral dimensions of financial well-being, said Reginald D. Tucker-Seeley, MA, ScM, ScD, at the 2017 AACR Science of Cancer Health Disparities Conference.

Read More ›

Page 1 of 20


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: